E-cadherin Expression Loss in T1 Invasive Ductal Carcinoma of theBreast as a Predictive Marker for Lymph Node Metastasis
E-cadherin Expression Loss in T1 Invasive Ductal Carcinoma of the Breast as a Predictive Marker for Lymph Node Metastasis
2
조회
0
다운로드
0
인용
0
참고문헌
초록
Abstract
Background : E-cadherin is a transmembrane glycoprotein, which has been shown to mediate calcium-dependent epithelial cell adhesion. A loss of E-cadherin expression has been associated with the tumor invasion and metastatic potential in some human cancers. The objective of this study was to evaluate E-cadherin expression in T1 breast ductal carcinomas in order to determine whether the loss of E-cadherin expression is correlated with lymph node metastasis. Methods : One hundred seventy nine patients with breast invasive ductal carcinoma, measuring less than 2 cm, were enrolled in this study. The subjects were divided into two groups on the basis of the status of the ipsilateral axillary lymph node, T1N1 (lymph node positive, n=91) or T1N0 (lymph node negative, n=88). None of the patients in this study had undergone preoperative chemotherapy. Formalin-fixed paraffin-embedded tissue sections of the primary breast cancers were stained by immunohistochemistry, using a mouse monoclonal antibody against E-cadherin. E-cadherin expression was designated as either positive (complete membranous staining) or negative (absent or incomplete membranous staining). Results : Benign breast parenchyma adjacent to invasive carcinoma was positive for E-cadherin. The loss of E-cadherin expression in the tumor was observed in 42% of patients of the T1N1 group, and in 24% of the T1N0 group. There was a significant correlation between the loss of E-cadherin expression and lymph node metastasis in the examined breast invasive ductal carcinomas (p=0.011). Conclusions : Our findings suggest that E-cadherin is an important molecule with regard to both tumor cell adhesion and metastasis, and its absence may constitue an early event in metastatic development. Therefore, E-cadherin may be a useful predictive marker for nodal metastasis in patients suffering from invasive ductal carcinoma.
참고문헌 (27)
- Hart IR, "Biology of tumor metastasis", 339, pp.1453~7 (1992)
- Day ML, "E-cadherin mediates aggregation-dependent survival of prostate and mammary epithelial cells through the retinoblastoma cell cycle control pathway", 274, pp.9656~64 (1999)
- Takeichi M, "Cadherin cell adhesion receptors as a morphogenetic regulator", 251, pp.1451~5 (1991)
- Bukholm IK, "E-cadherin and alpha-,beta-,and gamma-catenin protein expression in relation to metastasis in human breast carcinoma", 185, pp.262~6 (1998)
- Shapiro L, "Structural basis of cell-cell adhesion by cadherins", 374, pp.327~37 (1995)
- Eidelman S, "Expression of the cell-cell adhesion glycoprotein Cell-CAM 120", 80 in normal cell human tissues and tumors, 1989, pp.135, 101~10
- Vos CB, "E-cadherion inactivation in lobular carcinoma in situ of the breast:an early event in tumorigenesis", 76, pp.1131~3 (1997)
- Vleminckx K, "Geneticmanipulation of E-cadherin expression by epithelial tumor cellsreveals an invasion suppressor role", 66, pp.107~19 (1991)
- Frixen UH, "E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells", 113, pp.173~85 (1991)
- De Marzo AM, "E-cadherin expression as a marker of tumor aggressiveness in routinely processed radical prostatectomy specimens", 53, pp.707~13 (1999)
- Mayer B, "E-cadherin expression in primary and metastatic gastric cancer:down-regulation correlates with cellular dedifferentiation and glandular disintegration", 53, pp.1690~5 (1993)
- Schipper JH, "E-cadherin expression in squamous cell carcinomas of head and neck:inverse correlation with tumor dedifferentiation and lymph node metastasis", 51, pp.6328~37 (1991)
- Rasbridge SA, "cadherin cell adhesion molecule expression in breast carcinoma", pp.245~50
- Oka H, "Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis", 53, pp.1696~701 (1993)
- Siitonen SM, "Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer", 105, pp.394~402 (1996)
- Hunt NC, "Loss of E-cadherin expression associated with lymph node metastases in small breast carcinomas", 430, pp.285~9 (1997)
- Madhavan M, "Cadherins as predictive markers of nodal metastasis in breast cancer", 14, pp.423~7 (2001)
- Charpin C, "Reduced E-cadherin immunohistochemical expression in node-negative breast carcinomas correlates with 10-year survival", 109, pp.431~8 (1998)
- Jones JL, "E-cadherin relates to EGFR expression and lymph node metastasis in primary breast carcinoma", 74, pp.1237~41 (1996)
- Shiozaki H, "Expression of immunoreactive E-cadherin adhesion molecules in human cancers", 139, pp.17~23 (1991)
- Lipponen P, "Expression of E-cadherin(E-CD)as related to other prognostic factors and survival in breast cancer", 174, pp.101~9 (1994)
- Gagliardi G, "Changes in E-cadherin immunoreactivity in the adenoma-carcinoma sequence of the large bowel", 426, pp.149~54 (1995)
- Hirohashi S, "Inactivation of the E-cadherin-mediated cell adhesion system in human cancers", 153, pp.333~9 (1998)
- Graff JR, "Methylation patterns of the E-cadherin 5’ CpG island are unstable and reflect the dynamic,heterogeneous loss of E-cadherin expression during metastatic progression", 275, pp.2727~32 (2000)
- , jpathol2000, 15~9
- Rubin MA, "Ecadherin expression in prostate cancer:a broad survey using highdensity tissue microarray technology", 32, pp.690~7 (2001)
- Gupta A, "Role of E-cadherins in development of lymphatic tumor emboli", 97, pp.2341~7 (2003)